About Flinn
Flinn is a company based in Vienna (Austria) founded in 2022. Flinn has raised $28.61 million across 4 funding rounds from investors including Speedinvest, FFG Austrian Research Promotion Agency and Cherry Ventures. Flinn operates in a competitive market with competitors including Advarra, Leucine, PHARMASEAL, Datapharm and Health Language, among others.
- Headquarter Vienna, Austria
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28.61 M (USD)
in 4 rounds
-
Latest Funding Round
$20 M (USD), Series A
Feb 19, 2026
-
Investors
Speedinvest
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Flinn
Flinn has successfully raised a total of $28.61M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Flinn
Flinn has secured backing from 8 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Speedinvest, FFG Austrian Research Promotion Agency and Cherry Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of early-stage venture capital funding for European technology companies
|
Locked | Locked | Locked | |
|
Early-stage venture capital and startup acceleration are provided.
|
Locked | Locked | Locked | |
|
Investments in pre-seed and seed-stage startups are made by SquareOne.
|
Locked | Locked | Locked |
Investor details for Flinn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flinn
Investment portfolio details for Flinn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Flinn
Detailed financials for Flinn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flinn Comparisons
Peer comparison for Flinn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flinn
Flinn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Advarra, Leucine, PHARMASEAL, Datapharm and Health Language, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Global research compliance services including IRB and consulting are provided.
|
|
| Locked | Locked | Locked |
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory
|
|
| Locked | Locked | Locked |
SaaS platform for biopharmaceutical clinical trial management is offered.
|
|
| Locked | Locked | Locked |
Regulatory compliance software for pharma and healthcare professionals is provided.
|
|
| Locked | Locked | Locked |
Enterprise terminology management for medical coding is offered.
|
Detailed competitors of Flinn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flinn
Complete news archive for Flinn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flinn
Flinn was founded in 2022.
Flinn is headquartered in Vienna, Austria.
Flinn is a funded company, having raised a total of $28.61M across 4 funding rounds to date.
Flinn was founded in 2022 and is based in Vienna, Austria. An AI-enabled solution is provided by the company to medical device manufacturers for automating compliance processes. High-quality products are launched and operated through these automated systems. Operations focus on the manufacturing sector, where regulatory adherence is streamlined to support efficient product development and market entry.
Flinn's top competitors include Advarra, PHARMASEAL and REMATIQ.
Flinn has 8 investors. Key investors include Speedinvest, FFG Austrian Research Promotion Agency, Cherry Ventures, SquareOne, and Michael Reitermann.